The first-and-only FDA 510(k)-cleared, multi-parameter remote diagnostic platform evaluating 120 million+ data points per patient per day enabling continuous, simultaneous, and synchronous assessment of the heart, lungs, and upper vascular system.Learn more about us
Nanowear is the new standard-bearer for A.I-based remote diagnostics utilizing it's proprietary
cloth-based nanotechnology. Our nanosensors capture 15+ medical grade bio markers
directly from the skin, enabling a closed loop digital system for specific
machine-learning algorithms built on terabytes of unique human data.
Nanowear’s first of-its-kind platform enables a radical leap forward in telemedicine and empowering physician decision-making and improving outcomes without the need for physical visits. Consequently, Nanowear responds to market demand in multiple diagnostic and therapeutic applications in post-surgical recovery, virtual primary care, acute illness and procedure, chronic disease management, clinical research and military and industrial safety.
Because of Covid-19, the old world of healthcare delivery and diagnosis where a physician would physically
examine or touch a patient in-person via stethoscope, blood pressure cuff, thermometer, ECG monitor,
capnogram, etc., will be altered and potentially eliminated forever at all stages of the patient / physician
Telehealth platforms and services help marginally; a video conference with a physician alone is not enough to diagnose illness, manage a virus or identify worsening chronic disease; a medical-grade, A.I.based remote diagnostic is now an unquestioned need in the new paradigm of healthcare delivery.
Beginning with Post-surgical recovery and virtual primary care, Nanowear delivers high-fidelity alert diagnostics and bridges the gap between cost reduction and patient care, ultimately protecting improving lives and optimizing practictioner decision-making.